BRCA2 and pancreatic neoplasm: A similar decrease in cell survival was observed in human Capan-1 cells23, derived from a BRCA2-deficient pancreatic tumour, upon depletion of MUS81 (Fig. 1e and Supplementary Fig. 3f).